Form 4: Cardinal Health CIO's Share Transactions

Cardinal Health's Chief Information Officer, Michelle D. Greene, reported the acquisition of restricted stock units and subsequent sales of common shares.

Summary

• Michelle D. Greene, Chief Information Officer of Cardinal Health Inc. (CAH), reported changes in her beneficial ownership.
• On August 15, 2025, 3,476 common shares were acquired as a grant of restricted share units (RSUs) at a price of $0.00. These RSUs will vest in three equal annual installments beginning August 15, 2026.
• On August 15, 2025, 9,968 common shares were disposed of at $150.22 to satisfy tax withholding obligations related to the vesting of 6,787 RSUs and 16,362 performance share units.
• On August 19, 2025, 11,994 common shares were sold at a weighted average price of $148.76, with prices ranging from $148.20 to $149.19.
• On August 19, 2025, an additional 1,506 common shares were sold at a weighted average price of $149.28, with prices ranging from $149.20 to $149.33.
• Following these transactions, the reporting person beneficially owns 14,976 common shares.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, including equity grants and subsequent sales for tax purposes and personal portfolio management. This is a neutral event, typical for executive compensation, and does not indicate significant positive or negative company performance or outlook.

Positives

• Grant of 3,476 restricted share units (RSUs) to the Chief Information Officer, indicating ongoing equity compensation and alignment of interests.

Negatives

• Disposal of 9,968 shares for tax withholding purposes, reducing direct shareholding.
• Sale of 11,994 shares at a weighted average price of $148.76.
• Sale of 1,506 shares at a weighted average price of $149.28.

Future Outlook

NA

Industry Context

This filing details routine insider transactions for a Chief Information Officer at a major healthcare services and products company. Such transactions are common for executives receiving equity compensation and managing personal portfolios, and do not inherently reflect broader industry trends.

Comparison to Industry Standards

• NA. This Form 4 filing details individual insider transactions, which are not typically compared to industry-wide financial or operational benchmarks. The transactions reflect standard equity compensation practices and personal portfolio management for an executive.

Related Party Transactions

• The transactions involve an executive (Michelle D. Greene) and the company (Cardinal Health Inc.), which are considered related party transactions under SEC rules for insider reporting.

Stakeholder Impact

• Shareholders: The sales represent a slight reduction in direct insider ownership, but the grant of RSUs indicates continued alignment of executive incentives with shareholder interests. The overall impact is minimal as these are routine compensation-related transactions.

Next Steps

• First installment of 3,476 RSUs to vest on August 15, 2026, with subsequent installments annually thereafter.

Key Dates

Recommendation

The filing is a routine Form 4 detailing insider transactions (equity grant, tax withholding, and sales) by a Chief Information Officer. These transactions are typical for executive compensation and personal financial management and do not provide new fundamental information about Cardinal Health's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a compelling reason to buy or sell.

Keywords

Cardinal Health, CAH, SEC Form 4, Insider Trading, Stock Grant, Stock Sale, Restricted Stock Units, Equity Compensation, Michelle D. Greene